VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0927591
Sex: F
Age:
State: KS

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; Aches; Sweating; Dyspnea; Wheezing; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 38-year-old female (non-pregnant) patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EH9899), via an unspecified route of administration in left arm, on 21Dec2020, at a single dose, for COVID-19 immunization. The patient had no medical history and no concomitant medications. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The most recent COVID-19 vaccine was administered in a hospital. On 21Dec2020, the patient experienced chills, aches, sweating, dyspnea, wheezing, and fatigue. The events are considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the events on an unspecified date.

Other Meds:

Current Illness:

ID: 0927592
Sex: F
Age:
State: UT

Vax Date: 12/22/2020
Onset Date: 12/26/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: Blood sugar; Result Unstructured Data: Test Result:Average increase in blood sugar levels by 50 to 80; Comments: Average increase in blood sugar levels by 50 to 80 points, that haven't returned to prior levels yet.

Allergies:

Symptoms: Average increase in blood sugar levels by 50 to 80 points, that haven't returned to prior levels yet. Also achiness, and tiredness.; Average increase in blood sugar levels by 50 to 80 points, that haven't returned to prior levels yet. Also achiness, and tiredness.; Average increase in blood sugar levels by 50 to 80 points, that haven't returned to prior levels yet. Also achiness, and tiredness.; This is a spontaneous report from a contactable nurse (patient). A 61-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730) solution for injection via an unspecified route of administration on left arm on 22Dec2020 02:30 at a single dose for Covid-19 immunization. Medical history included CREST Syndrome, type 2 diabetes, osteoarthritis, allergies to Sulfa and Dermabond tape. The patient previously took acetylsalicylic acid (ASPIRIN) and experienced allergy. The patient took other medications in the last two weeks. On 26Dec2020, the patient experienced average increase in blood sugar levels by 50 to 80 points, that haven't returned to prior levels yet. Also, she experienced achiness, and tiredness on 26Dec2020. No treatment received for the events. The patient was not diagnosed with Covid-19 and has not been tested prior to vaccination. Outcome of the events was unknown. No follow-up activities are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 0927593
Sex: F
Age:
State: TN

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; She was pregnant at the time of vaccination; She was pregnant at the time of vaccination; She was pregnant at the time of vaccination; This is a spontaneous report from a contactable nurse (patient). A 38-year-old pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) solution for injection, via an unspecified route of administration on left arm on 01Jan2021 15:00 at a single dose for COVID-19 immunization. Medical history included diabetes, and depression. Concomitant medications included escitalopram oxalate (LEXAPRO), ascorbic acid, biotin, minerals NOS, nicotinic acid, retinol, tocopherol, vitamin b NOS, vitamin D NOS (PRENATAL VITAMINS [ASCORBIC ACID;BIOTIN;MINERALS NOS;NICOTINIC ACID;RETINOL;TOCOPHEROL;VITAMIN B NOS;VITAMIN D NOS]), progesterone (PROGESTERONE), and colecalciferol (VITAMIN D [COLECALCIFEROL]). The patient reported she was pregnant at the time of vaccination on 01Jan2021 15:00. She was at 9 weeks gestational period and will be due to deliver on 01Aug2021. The patient experienced headache on 02Jan2021 16:00 but did not receive any treatment. Outcome of the event headache was recovering while for the other event was unknown. No follow-up activities are needed. No further information is expected.

Other Meds: LEXAPRO; PRENATAL VITAMINS [ASCORBIC ACID;BIOTIN;MINERALS NOS;NICOTINIC ACID;RETINOL;TOCOPHEROL;VITAMIN B NOS; ; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0927594
Sex: M
Age:
State: TX

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left eyelid began to twitch and to this day has been off and on everyday; This is a spontaneous report from a contactable healthcare professional. A 36-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730) solution for injection, intramuscular on left arm on 18Dec2020 08:00 at a single dose for COVID-19 immunization. Medical history included seasonal allergies. Concomitant medication included liothyronine. On 19Dec2020 at 23:00, patient reported his left eyelid began to twitch and up to this day it has been off and on everyday. No treatment was given. The event was reported as non-serious. The patient was not diagnosed of Covid-19 prior to vaccination and has not been tested for Covid-19 since vaccination. Outcome of the event was unknown. No follow-up activities are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 0927595
Sex: F
Age:
State: PA

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Increased left hand pain. More pain than typical arthritis pain; This is a spontaneous report from a contactable consumer. A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), via an unspecified route of administration at the left arm on 30Dec2020 17:00 at a single dose for COVID-19 immunization at a hospital. Medical history included ventricular septal defect (VSD), psoriasis, inflammatory arthritis, and migraines. Concomitant medications included fish oil, magnesium, paracetamol (TYLENOL ARTHRITIS). The patient previously took naproxen and experienced allergies. The patient experienced increased left hand pain that was more pain than typical arthritis pain on 31Dec2020, 12:00. The patient did not received any treatment for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for it since the vaccination. The patient has not recovered from the events.

Other Meds: ; ; TYLENOL ARTHRITIS

Current Illness:

ID: 0927596
Sex: M
Age: 30
State: NJ

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Unknown as patient was transferred to local emergency room.

Allergies: NKA

Symptoms: The patient complained of dizziness, itching, immense sweating within one hour of the vaccine administration. Over the next 12-24 hrs the patient had bloody emesis, diarrhea and noticeable swelling of tongue/lips.

Other Meds: None reported

Current Illness: None reported

ID: 0927597
Sex: F
Age:
State: MT

Vax Date: 12/17/2020
Onset Date: 12/23/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash dots on back of both hands/rash on shoulders and mid-back/rash on upper legs/rash on lower legs and arms; This is a spontaneous report received from a contactable nurse (who is also the patient). A 47-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EH9899), intramuscular in left arm, on 17Dec2020 13:00, at single dose, for COVID-19 immunization. Medical history included ulcerative colitis diagnosed in 2002, and "Allergies to medications, food, or other products: Sulfa medications - cause rash". The patient is not pregnant. Concomitant medication included mesalamine, lithium, lamotrigine and an unspecified birth control pill. It was reported that on 23Dec2020 15:00 (also reported as 17:00, pending clarification), she noticed rash dots on back of both hands. On 26Dec2020 15:00, she noticed rash on shoulders and mid-back. On 28Dec2020 17:00, she noticed rash on upper legs. On 29Dec2020 17:00, she noticed rash on lower legs and arms. On 01Jan2021, she went to urgent care for evaluation and was treated with methylprednisolone dose pack. The patient did not receive any other vaccines with 4 weeks prior to BNT162B2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was recovering. The reporter assessed the report as non-serious.

Other Meds: MESALAMINE; ;

Current Illness:

ID: 0927598
Sex: M
Age:
State:

Vax Date: 12/18/2020
Onset Date: 12/01/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201231; Test Name: COVID-19; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: got COVID-19 from his son and tested positive; got COVID-19 from his son and tested positive; This is a spontaneous report from a contactable physician. A 51-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got COVID-19 from his son and he tested positive 31Dec2020. The patient's son got the COVID-19 virus on 20Dec202020. The patient is due to have 2nd vaccine on 07Jan2021. Outcome of the events was unknown. Information on batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 virus test positive cannot be totally excluded. The case will be reassessed if additional information becomes available.

Other Meds:

Current Illness:

ID: 0927599
Sex: F
Age: 35
State: MI

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: Chills, muscle pain, headache, pain at injection site

Other Meds: None

Current Illness: None

ID: 0927600
Sex: F
Age:
State: OK

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:101

Allergies:

Symptoms: Arm pain at injection site; fever of 101; chills; severe body aches; mild headache; nausea; This is a spontaneous report from a contactable nurse. A 26-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot numbe: EK5730), via an unspecified route of administration on the left arm on 31Dec2020 10:00 at single dose for COVID-19 immunisation. Medical history included anxiety, and covid prior vaccination: Yes. Concomitant medication included sertraline hydrochloride (ZOLOFT). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date. The patient experienced arm pain at injection site, fever of 101, chills, severe body aches, mild headache, nausea on 01Jan2021. The patient received no treatment. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: ZOLOFT

Current Illness:

ID: 0927601
Sex: F
Age:
State: MI

Vax Date: 12/29/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201111; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: Pain on injection site in couple of days; tiredness; headache; muscle pain; joint pain; weakness; mild fever; sore throat; profused sweating; This is a spontaneous report from a contactable nurse. A 43-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 vaccine; lot EL0140, expiration date unspecified), via an unspecified route of administration on 29Dec2020 10:30 at single dose at left arm, for COVID-19 immunization. Medical history included allergies to seafoods occasionally. There were no concomitant medications. The patient was not pregnant at the time of vaccination. On 31Dec2020 23:00, the patient experienced pain on injection site in couple of days, tiredness, headache, muscle pain, joint pain, weakness, mild fever, sore throat and profuse sweating. Therapy for the events included Tylenol 500 mg. It was reported that the patient was vaccinated at the hospital. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine and no other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had been tested for COVID-19. The patient underwent a lab test and procedure which included nasal swab which was negative on 11Nov2020. Outcome of events was unknown.

Other Meds:

Current Illness:

ID: 0927602
Sex: F
Age:
State: NV

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lip tingle; Tongue- back, Each side-felt full; Eye lids dropped; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 68-year-old female patient (not pregnant) received first dose of bnt162b2 (BNT162B2 also reported as COVID 19, brand Pfizer, lot EK5730, expiry date not reported), intramuscular in the left arm on 21Dec2020 16:15 at single dose, for Covid-19 immunisation. Medical history included asthma. Prior to vaccination the patient was not diagnosed with COVID-19. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included liothyronine, levothyroxine sodium (LEVOXYL), ergocalciferol (VIT D) and fluticasone propionate (FLOVENT). The patient experienced lip tingle, tongue- back, each side-felt full, eye lids dropped on 21Dec2020 16:15. He went to professional office/clinic visit/Emergency room/department or urgent care. An unknown treatment was given to the patient. The outcome of events was recovered.

Other Meds: ; LEVOXYL; VIT D; FLOVENT

Current Illness:

ID: 0927603
Sex: F
Age:
State: CO

Vax Date: 12/20/2020
Onset Date: 12/20/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Near syncope; lightheaded/dizzy; vision narrow; Tingling in lips; This is a spontaneous report from a contactable physician. A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Eh9899), via an unspecified route of administration on 20Dec2020 09:00 in left arm at single dose for COVID-19 immunization. Medical history was reported as none. The patient's concomitant medications were not reported. The patient experienced near syncope, lightheaded, dizzy, vision narrow and tingling in lips on 20Dec2020 09:30 AM. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment given to the patient for the events. The outcome of the events was recovered on unspecified date. The event was considered non serious as it did not results in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Other Meds:

Current Illness:

ID: 0927604
Sex: F
Age:
State: MN

Vax Date: 12/23/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: R knee pain and effusion 1 week after receiving the vaccine; R knee pain and effusion 1 week after receiving the vaccine; This is a spontaneous report from a contactable physician. A 52-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0104), intramuscular at the left arm on 23Dec2020 12:00 at a single dose for COVID-19 immunization at a hospital in an emergency room/department or urgent care. Medical history included hypothyroidism, allergies with sulfa. The patient's concomitant medications were not reported. The patient experienced right knee pain and effusion 1 week after receiving the vaccine on 30Dec2020, 06:00. The patient an unspecified NSAIDS as a treatment for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications the patient received within 2 weeks. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for it since the vaccination. The patient has not recovered from the events.

Other Meds:

Current Illness:

ID: 0927605
Sex: M
Age:
State: IL

Vax Date: 01/02/2021
Onset Date: 01/02/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Coughing; This is a spontaneous report from a contactable other healthcare professional. A 28-year-old male patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknown), via an unspecified route of administration on 02Jan2021 12:00 single dose (left arm, dose 1) for COVID-19 immunization. Medical history included bipolar disorder from an unknown date. No other vaccine in four weeks was given. Patient took other unspecified medications in two weeks. The patient has no COVID prior vaccination. The patient was not tested for COVID post vaccination. Patient has no known allergies. The patient experienced coughing on 02Jan2021 12:30 with outcome of not recovered. Treatment was not given. The reporter considered the event as non-serious. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0927606
Sex: F
Age:
State: IL

Vax Date: 01/01/2021
Onset Date: 01/02/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20210102; Test Name: corneal topographies; Result Unstructured Data: Test Result:determined I had corneal edema; Comments: The swelling in the cornea increased her near-sightedness from -1.25 to -1.75.; Test Date: 20210102; Test Name: corneal topographies; Result Unstructured Data: Test Result:vision and corneal topographies returned back to n

Allergies:

Symptoms: Temporary blurred vision; increased her nearsightedness from -1.25 to -1.75; corneal edema/ Corneal topographies showed swelling in the cornea; This is a spontaneous report from a contactable other healthcare professional. A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number EL0140), intramuscular (left arm, dose number 1) on 01Jan2021 16:45 at single dose for COVID-19 immunization. Medical history included known allergies to penicillin and sulfa antibiotics, hormonal migraines, and gluten intolerance from an unknown date and unknown if ongoing. Concomitant medication included cetirizine hydrochloride (ZYRTEC), and spironolactone from unspecified dates for unspecified indications taken within two weeks. No other vaccine was taken within four weeks. Patient has not COVID prior vaccination. Patient has not been tested for COVID post vaccination. The patient experienced temporary blurred vision in the right eye on 02Jan2021. Patient stated that she is an optometrist so she performed a variety of tests and determined she had corneal edema. Corneal topographies showed swelling in the cornea, increased her nearsightedness from -1.25 to -1.75. By the time she left work 7 hours later, her vision and corneal topographies returned back to normal. Treatment was not given for the events. Event outcome was recovered on 02Jan2021. The reporter assessed the event was non-serious.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE];

Current Illness:

ID: 0927607
Sex: F
Age:
State: NV

Vax Date: 12/16/2020
Onset Date: 12/16/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: heart rate; Result Unstructured Data: Test Result:Increased

Allergies:

Symptoms: Sore arm where vaccination was administered; Intermittent nausea; Increased heart rate; anxiety; Tiredness; This is a spontaneous report from a contactable nurse (Patient). A 23-year-old female patient received the first dose of bnt162b2 (PFIZER COVID 19 VACCINE, lot number: EH9899, Batch/lot number: EK5730 as reported), via an unspecified route of administration at Right arm on 16Dec2020 17:00 at a single dose for COVID-19 immunization. Medical history included General Anxiety Disorder, depression, and COVID-19. The patient had no known allergies. Concomitant medication included escitalopram oxalate (LEXAPRO), levonorgestrel (NORTREL[LEVONORGESTREL]). The patient experienced sore arm where vaccination was administered, intermittent nausea for 3 days, increased heart rate and anxiety for 1.5 days, and tiredness; all on 16Dec2020. There was no treatment for the adverse events. The patient did not test positive for COVID post vaccination. The event Nausea recovered in 19Dec2020, while patient recovered from the other events in Dec2020. The vaccine was administered at the hospital. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The events were considered as non-serious.

Other Meds: LEXAPRO; NORTREL [LEVONORGESTREL]

Current Illness:

ID: 0927608
Sex: F
Age:
State: HI

Vax Date: 12/28/2020
Onset Date: 12/29/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: vaccination burning, itching redness to eye lids; vaccination burning, itching redness to eye lids; vaccination burning, itching redness to eye lids; It appears I have eye shadow; peeling/dryness of skin around lips; peeling/dryness of skin around lips/It appears I have eye shadow but peeling is not visible; burning and itch of lip region; burning and itch of lip region; muscle spasm; Neuralgia; medium-severe headache; nausea; sensitive to light; mild confusion; lack of concentration; This is a spontaneous report from a contactable nurse (patient herself). A 36-years-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), intramuscular in 28Dec2020 08:30 at a single dose in the left arm as COVID vaccine. Medical history included history of Grave's disease at age 19 which has resolved without medication for many years. The patient had no known allergies: no allergies to medications, food, or other products. The patient was not pregnant at the time of the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medications. The patient had no other vaccine in four weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not taking any daily medications. On 28Dec2020 (day 1), patient had no significant symptoms. On 29Dec2020 (day 2), patient had medium-severe headache, nausea, sensitive to light, mild confusion and lack of concentration. On 30Dec2020 (day 3), patient had muscle spasm that wake from a sound sleep in biceps tendon region, and neuralgia in left upper and lower extremities. On 31Dec2020 (day 4), patient had peeling/dryness of skin around lips, burning and itch of lip region. On 01Jan2021 (day 5), patient had post vaccination burning, itching redness to eye lids. Patient realized patient should photo her journey. It appeared patient have eye shadow but peeling was not visible due to moisturizer and bacitracin "ito" try and sooth the pain. Patient can send at additional request since patient can't upload. The patient was not tested for COVID post vaccination. Therapeutic measures were taken as a result of the event "peeling/dryness of skin around lips/it appeared patient have eye shadow but peeling was not visible". No treatment received in response to the other events reported. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). The outcome of the events medium-severe headache, nausea, sensitive to light, mild confusion, lack of concentration, muscle spasm, neuralgia in left upper and lower extremities, dryness of skin around lips, "peeling/dryness of skin around lips/it appeared patient have eye shadow but peeling was not visible", burning and itch of lip region, post vaccination burning, itching redness to eye lids, and "it appeared patient have eye shadow" was not recovered. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 0927609
Sex: F
Age:
State: CA

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: palpitations; 3 days straight skin rash with itching on her left leg; muscle soreness on arm of injection site; muscle soreness on arm of injection site; This is a spontaneous report from a contactable other healthcare professional (patient). A 20-year-old female patient received the first dose of bnt162b2 (Covid 19 vaccine, brand: Pfizer) via an unspecified route of administration in right arm on 31Dec2020 10:00 at a single dose for COVID-19 immunization in a hospital. Medical history included GERD and Strep throat, both from unknown dates. Concomitant medication included benzylpenicillin (PENICILLIN). The patient did not receive other vaccine in four weeks. The patient experienced palpitations - 3 days straight skin rash with itching on her left leg, muscle soreness on arm of injection site, all on 31Dec2020 11:00. The events were reported as non-serious. The patient did not receive treatment for the events. The patient had not recovered from the events. Information on the lot number/Batch number was requested.

Other Meds: PENICILLIN

Current Illness:

ID: 0927610
Sex: F
Age:
State: MI

Vax Date: 12/28/2020
Onset Date: 12/29/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201124; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative; Test Name: COVID-19 test; Result Unstructured Data: Test Result:unknown

Allergies:

Symptoms: Some skin rashes as reaction when there is an allergen; Rash/They red bumps and itches; Rash/They red bumps and itches; This is a spontaneous report from a contactable other hcp. A 49-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number EL0140), intramuscular (arm left) on 28Dec2020 12:00 at single dose (dose 1) for COVID-19 immunization. Medical history included psoriasis from an unknown date and allergies to medications, food, or other products (unspecified). The patient was taking unspecified concomitant medications including a vaccine within 2 weeks. Patient did not receive other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19 with unknown results. On 29Dec2020 04:00, the patient had some skin rashes as a reaction when there is an allergen. After the vaccines, she has been having occasional rashes that pops at different places. They were red bumps and itches. She stated she needed to keep antihistamines CLARITIN/BENADRYL on the clock. Event outcome was not recovered. The patient underwent lab tests and procedures which included COVID test (Nasal swab): negative on 24Nov2020. Event outcome was not recovered. Patient considered the events as non-serious.

Other Meds:

Current Illness:

ID: 0927611
Sex: F
Age:
State: NY

Vax Date: 12/30/2020
Onset Date: 01/02/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: nausea; vomiting/Severe bout of vomiting this morning; vertigo; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right deltoid on 30Dec2020 at 15:00 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 02Jan2021 at 05:00, the patient experienced nausea, vomiting/severe bout of vomiting, and vertigo. The patient experienced these same symptoms again on 02Jan2021 at 20:00. The clinical outcomes of nausea, vomiting, and vertigo were unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0927612
Sex: M
Age:
State: CA

Vax Date: 12/19/2020
Onset Date: 12/20/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild soreness left arm for one day post vaccination; This is a spontaneous report from a contactable physician (patient). A 55-year-old male patient received bnt162b2 (BNT162B2 also reported as Covid-19 vaccine; lot number: EJ1685; expiration date: unknown), via an unspecified route of administration left arm on 19Dec2020 05:00 PM at a single dose for covid-19 vaccination. The patient has no medical history. The patient has no known allergies. The patient was not patient diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not have any other medications the patient received within 2 weeks of vaccination. It was reported that the patient received the COVID-19 vaccine in a hospital on 19Dec2020 05:00 PM. On 20Dec2020, the patient had mild soreness left arm for one day post vaccination. The patient has not been tested for COVID-19 since the vaccination. The patient considered the events as non-serious. No treatment received for the adverse event. The outcome of the event was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0927613
Sex: M
Age:
State: MI

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; Headaches; This is a spontaneous report from a contactable healthcare professional. A 24-year-old male patient received bnt162b2 (BNT162B2 also reported Covid 19 vaccine; lot number: EJ1686; expiration date: unknown), via an unspecified route of administration on 29Dec2020 15:30 at a single dose for covid-19 immunization. Medical history included sulfa antibiotics. The patient's concomitant medications were not reported. The patient previously took amoxicillin but had allergies. The patient was not patient diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not have any other medications the patient received within 2 weeks of vaccination. The patient reported the headache started 20 hours post vaccination (30Dec2020 11:30) which did not resolved with acetaminophen but was resolved after night's sleep (12-18 hours later). The patient also had fatigue which was worst on the first full day after shot but was back to normal after 3 days. The outcome of the events was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0927614
Sex: M
Age:
State: WI

Vax Date: 12/23/2020
Onset Date: 01/02/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20210102; Test Name: Influenza; Result Unstructured Data: Test Result:Unknown Results; Test Date: 20210102; Test Name: Nasal Swab/COVID-19 Nucleic Acid Amplification Test; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: was diagnosis with COVID-19 through nasopharyngeal swab today, 02Jan2021; was diagnosis with COVID-19 through nasopharyngeal swab today, 02Jan2021; This is a spontaneous report from a contactable pharmacist (patient himself). A 34-year-old male patient received his first dose of bnt162b2 (BNT162B2 also reported as COVID 19 brand Pfizer, lot EJ1685, expiry date not reported), via an unspecified route of administration in his right arm on 23Dec2020 15:30 at single dose, for Covid-19 vaccination. The patient's medical history was not reported. Prior to vaccination the patient was not diagnosed with COVID-19. He did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included bupropion. The patient informed that he was diagnosed with Covid-19 through nasopharyngeal swab (COVID-19 Nucleic Acid Amplification test) on 02Jan2021 01:00 and Influenza virus test was unknown results (02Jan2021). It was unknown if there was a treatment used. The outcome of event was not recovered.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given. Case will be reevaluated based on follow-up information

Other Meds:

Current Illness:

ID: 0927615
Sex: F
Age:
State: TN

Vax Date: 01/02/2021
Onset Date: 01/02/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: redness at injection site; Mildly tender injection site; slight swelling at injection site; This is a spontaneous report from a contactable nurse. A 64-year-old non-pregnant female patient received bnt162b2 (BNT162B2 also reported as COVID-19 vaccine; lot number: EL 3246; expiration date: unknown), via an unspecified route of administration left arm on 02Jan2021 15:45 at a single dose for covid-19 vaccination. Medical history included HTN (hypertension) and controlled PAT (paroxysmal atrial tachycardia). Concomitant medication included unspecified medication. The patient previously took cephalexin [reported as Cephlexin]. The patient was not patient diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the COVID-19 vaccine in a public health clinic/facility. It was reported that the patient had mildly tender injection site, slight swelling and redness at injection site on 02Jan2021 08:00 PM. The reporter did not consider the event serious. The patient was not tested for COVID-19 since the vaccination. The patient did not received treatment for the adverse event. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0927616
Sex: F
Age:
State: CA

Vax Date: 12/30/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache and nausea with vomiting; Headache and nausea with vomiting; Headache and nausea with vomiting; This is a spontaneous report from a contactable Other HCP (patient). A 29-year-old female patient received the first dose of BNT162B2 (Lot number and expiry date not reported), intramuscular on 30Dec2020 07:15 at single dose in the left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination, the patient has not been tested for COVID-19. The patient was not pregnant at the time of vaccination. On 01Jan2021, the patient experienced headache and nausea with vomiting. No treatment received for all the events. The outcome of the events was recovered on an unspecified date. The following information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0927617
Sex: F
Age:
State: NC

Vax Date: 12/28/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20210102; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Body aches, low grade fever, chills 4 days after vaccine; Body aches, low grade fever, chills 4 days after vaccine; Body aches, low grade fever, chills 4 days after vaccine; This is a spontaneous report from a contactable other HCP (patient). A 32-year-old female patient received the first dose of BNT162B2 (lot number: EJ1685), via an unspecified route of administration on 28Dec2020 09:45 at single dose in the right arm for COVID-19 immunization. Medical history included hypothyroidism from an unknown date. Concomitant medication included levothyroxine and topiramate. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient experienced body aches, low grade fever, chills 4 days after vaccine on 01Jan2021 15:30. The patient did not receive any treatment for the events. The patient underwent lab tests and procedures which included nasal swab: negative on 02Jan2021. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: ;

Current Illness:

ID: 0927618
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: herpes zoster on the left and mid back in the L1 distribution; This is a spontaneous report from a contactable physician (patient). A 34-year-old non pregnant female patient received bnt162b2 (lot number: EK9231), via an unspecified route of administration on 22Dec2020 in left arm at single dose for Covid-19 immunization. Medical history was none. There were no other medications the patient received within 2 weeks of vaccination. The most recent COVID-19 vaccine was administered in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On unspecified date, the patient experienced herpes zoster on the left and mid back in the L1 distribution. She was not otherwise immunosuppressed and never had zoster before. The event resulted in doctor or other healthcare professional office/clinic visit. The outcome of the event was recovered with sequel (reported as Recovered with lasting effects). Therapeutic measures were taken as a result of the event which included Valacyclovir. The event was considered as non-serious.

Other Meds:

Current Illness:

ID: 0927619
Sex: F
Age:
State: GA

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: On the third morning after the shot, at 3 a.m., was awakened to a racing heart. The racing heart was on and off until getting out of the bed at 7 a.m.; Oe spot was visible on the upper left arm; Rash on lower right leg above the ankle; This is a spontaneous report from a contactable consumer (patient). A 22-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the right arm on 31Dec2020 at 13:30 at a single dose for COVID-19 immunization at the Public Health Clinic facility (as reported). The patient's medical history and concomitant medications were not reported. The patient has no known allergies. The patient is not pregnant. The patient was has not received any other vaccine in four weeks and has not have other medications in two weeks. On 31Dec2020 at 17:30, patient reported of rash on lower right leg above the ankle appeared the evening of the shot. Then one spot was visible on the upper left arm the day after the shot (01Jan2021). On the third morning after the shot (03Jan2021), at 3 A.M., patient was awakened to a racing heart. The patient reported that the racing heart was on and off until getting out of the bed at 7 A.M. The patient did not receive treatment in response to the events. The patient assessed the events as non-serious. The outcome of the events was unknown. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since vaccination. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0927620
Sex: F
Age:
State: IN

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever of 2-3 degrees; slept most of the day; didn't feel well at all; headache; achey; tired/exhausted; sore arm; woke her up briefly; This is a spontaneous report from a contactable healthcare professional (patient). A 49-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration in the right arm on 31Dec2020 10:00 at a single dose for COVID-19 immunization. The patient was vaccinated in a hospital facility. Medical history included spending 4-6 hrs/day face-to-face with Covid patients for months since early Apr2020. The patient has no known allergies. The patient has no covid prior vaccination, and she was not tested for covid post vaccination. The patient's concomitant medication included multivitamin. The patient did not receive other vaccine in last four weeks. The patient was vaccinated on 31Dec2020 at 10am for her 1st Pfizer vaccine. No symptoms for 6-8 hrs. By bedtime at 06:00 PM, she experienced headache, achey, tired, and sleeping on her sore arm woke her up briefly. Next day on 01Jan2021, more achey, exhausted, fever of 2-3 degrees, slept most of the day and didn't feel well at all. She could tell that her body was fighting something, but she is much better 48 hours out. The patient did not receive any treatment for the reported adverse events. She stated she had no regrets. She stated that she loves Pfizer, because it has given hope. She just wasn't expecting any side effects after the 1st vaccine, only for the 2nd. Anecdotally, it seemed her hospital coworkers who have had Covid react more to the 1st vaccine, possibly for them, 1st vaccine is like the 2nd. She doesn't know if she has had Covid, but as an Acute Care PT on Covid units, she spends 4-6 hrs/day face-to-face with Covid patients for months since early Apr2020. She stated that possible her immune system already recognizes Covid. She is curious. No complaints, only curious. Again, she said thank you. She stated that she has seen too many good people die this year, thus, she didn't hesitate on the vaccine. The outcome of the events was recovered in Jan2021. The report was considered non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0927621
Sex: F
Age:
State: NY

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201231; Test Name: fever; Result Unstructured Data: Test Result:102.4

Allergies:

Symptoms: I experienced rigors; Extreme fatigue; Fever spiked to 102.4 in the evening, the day after vaccine.; Very mild headache and very mild queasiness; Very mild headache and very mild queasiness; This is a spontaneous report from a contactable nurse (patient). A 50-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at the left arm on 31Dec2020 at 11:45 at a single dose for COVID-19 immunization in the hospital. The patient has not have any vaccines in four weeks and did not take any medications in two weeks. The patient is not pregnant. Medical history included asthma, grade 1 casein allergy, environmental allergies, mild hypertension and high cholesterol. Concomitant medications included montelukast sodium (SINGULAIR), fexofenadine hydrochloride (ALLEGRA), nifedipine (PROCARDIA) and atorvastatin (LIPITOR). On 31Dec2020 at 09:00 PM, approximately 9 hours after receiving the vaccine, the patient experienced rigors which lasted much of the night. Extreme fatigue. Patient reported that ibuprofen was taken with no relief. Tylenol taken the next day. Fever spiked to 102.4 in the evening, the day after vaccine. The patient did not record her temperature overnight during rigors. The patient also reported of a very mild headache and very mild queasiness. The patient also took Benadryl, self-administered per MD. The symptoms were gone by the morning of the second day. The patient assessed the events as non-serious. The patient recovered from the events on an unspecified date in Jan2021. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since vaccination. Information about Lot/Batch number has been requested.

Other Meds: SINGULAIR; ALLEGRA; PROCARDIA [NIFEDIPINE]; LIPITOR [ATORVASTATIN]

Current Illness:

ID: 0927622
Sex: M
Age:
State: TX

Vax Date: 12/17/2020
Onset Date: 12/25/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201225; Test Name: Fever; Result Unstructured Data: Test Result:100.4

Allergies:

Symptoms: Joint pain; Pain at injection site; Fever of 100.4; This is a spontaneous report from a contactable healthcare professional. A 55-year-old male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on 17Dec2020 14:00 in right arm at single dose for COVID-19 immunization. Medical history included allergies to Ovaltine from an unknown date and unknown if ongoing. Concomitant medication included atorvastatin calcium (LIPITOR). On 25Dec2020, the patient experienced pain at injection site x 2 days, fever of 100.4 and joint pain at day 7. The facility where the most recent COVID-19 vaccine was administered was in a military base. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of event pain at injection site was recovered in Dec2020 and the outcome of the remaining events was recovered on unspecified date. The event was considered non serious as it did not results in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Other Meds: LIPITOR [ATORVASTATIN CALCIUM]

Current Illness:

ID: 0927623
Sex: M
Age:
State:

Vax Date: 12/19/2020
Onset Date: 12/01/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201230; Test Name: blood work; Result Unstructured Data: Test Result:has IgG antibodies; Comments: he had his blood work last 30Dec2020 and confirmed he has IgG antibodies.

Allergies:

Symptoms: fever; chills; nausea; headache; fatigue; had a local reaction of a "patch of inflammation, redness, burning sensation- similar to a 2nd degree burn."; had a local reaction of a "patch of inflammation, redness, burning sensation- similar to a 2nd degree burn."; had a local reaction of a "patch of inflammation, redness, burning sensation- similar to a 2nd degree burn."; This is a spontaneous report from a contactable physician (patient). A 64-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number not reported), via an unspecified route of administration on 19Dec2020 at a single dose for Covid-19 immunization. Medical history included pneumonia from 03Aug2020 to 08Aug2020. Concomitant medications were not reported. Patient had the first COVID-19 vaccine dose on 19Dec2020. Patient said he had a "pretty strong reaction" of fever, chills, nausea, headache, fatigue in Dec2020. Felt ill until day 2, started feeling better on day 3. Patient also had a local reaction of a "patch of inflammation, redness, burning sensation- similar to a 2nd degree burn" in Dec2020. Patient also mentioned he had his blood work last 30Dec2020 and confirmed he has IgG antibodies. Patient then asked "I want to get the second dose, is it okay to get the vaccine?" The outcome of the events 'fever, chills, nausea, headache, fatigue' was recovering while unknown for the other events. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0927624
Sex: F
Age:
State: MD

Vax Date: 12/24/2020
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: cholesterol; Result Unstructured Data: Test Result:high

Allergies:

Symptoms: swollen/sore lymph node in left neck/clavicle area after about several days; swollen/sore lymph node in left neck/clavicle area after about several days; This is a spontaneous report from a contactable nurse (patient herself). A 53-year-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; Solution for injection; lot number: EL0140; expiration date: not known), via an unspecified route of administration on 24Dec2020 08:00 (left arm) at single dose for covid-19 immunisation. Medical history included depression, hypertension (HTN), and high cholesterol. The patient had allergies with sulfa and beta blockers. The patient's concomitant medications were not reported. The patient previously took pravastatin sodium (PRAVACHOL) and experienced allergies. The patient was vaccinated at a hospital and was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to bnt162b2 vaccine and received other medications within 2 weeks of vaccination but were unspecified. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced swollen/sore lymph node in left neck/clavicle area after about several days on an unspecified date (reported as "01Dec2020", pending clarification). The reported events were non-serious. The patient did not receive treatment for these reported events. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0927625
Sex: F
Age:
State: PA

Vax Date: 12/28/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: On day 6, developed large, urticarial hives at injection site associated with significant burning, aching, and tingling of entire right extremity; On day 6, developed large, urticarial hives at injection site associated with significant burning, aching, and tingling of entire right extremity; On day 6, developed large, urticarial hives at injection site associated with significant burning, aching, and tingling of entire right extremity; Developed diffuse, pinpoint, non-pruritic, flat rash to trunk.; redness, and itching at injection site; redness, and itching at injection site; Developed mild hives at injection site/large, urticarial hives at injection site; This is a spontaneous report from a contactable nurse (patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EK9231), intramuscular from 28Dec2020 08:00 at single dose in the right arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took cephalosporin and experienced allergies. The patient developed mild hives, redness, and itching at injection site on days 2 and 3. Symptoms resolved entirely on days 4 and 5. On day 6, developed large, urticarial hives at injection site associated with significant burning, aching, and tingling of entire right extremity. On 30Dec2020, she developed diffuse, pinpoint, non-pruritic, flat rash to trunk. Rash resolved with Benadryl. Extremity pain and burning persists despite Benadryl. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination and did not receive any other medications within 2 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did receive treatment for the events which included Benadryl and Pepcid. The events resulted in emergency room/department or urgent care. The outcome of the events "Developed mild hives at injection site/large, urticarial hives at injection site", "On day 6, developed large, urticarial hives at injection site associated with significant burning, aching, and tingling of entire right extremity" was unknown; for events "Paraesthesia" and "pain in extremity" was not recovered; and for the other events was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0927626
Sex: F
Age:
State:

Vax Date: 12/19/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: small rash that has been getting larger; This is a spontaneous report from a contactable consumer reported for herself. A female patient of an unspecified age (reported as age: 30, unit: unknown) received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on 19Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Laboratory employee received her first dose of vaccine on 19Dec2020. On 01Jan2021, she developed a small rash that has been getting larger that she has been treating with Benadryl. She is calling to see if she can receive the second dose. The outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0927627
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: mild hives on the chest a few hours after receiving the vaccine; her asthma kept flaring up with shortness of breath; her asthma kept flaring up with shortness of breath; breastfeeding; breastfeeding; This is a spontaneous report from a contactable consumer (patient). This consumer reported for both herself and baby. This is a mother report. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient is a breastfeeding mother. The patient experienced mild hives on the chest a few hours after receiving the vaccine and her asthma kept flaring up with shortness of breath. She took Benadryl and everything went away. Outcome of the events was recovered. The patient asked if she had side effects to the vaccine is it ok for her to get the second dose. Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021003624 mother/baby

Other Meds:

Current Illness:

ID: 0927628
Sex: F
Age:
State: VA

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: whole body ached/shingles like pain in my butt/legs/groin to where my skin hurt to touch it/pain was excruciating/the vaccine amplified the pain; sore arm; progressed to Flu like symptoms; Arthritis in her knee/vaccine amplified the pain; This is a spontaneous report from a contactable healthcare professional. A 42-year-old female patient received bnt162b2 (BNT162B2; also reported as COVID-19 vaccine; lot number: EH 9899; expiration date: unknown), intramuscular left arm on 30Dec2020 20:30 at a single dose for covid-19 vaccination. Medical history included arthritis in my knee, labrum hip tear, HSV2 (herpes simplex virus type 2), haven't had an OB [pending clarification] in over 2 years and herpes. Concomitant medication included omeprazole (PRILOSEC), ondansetron (ZOFRAN MELT), alprazolam (XANAX; reported as Xanax ER), lamotrigine (LAMICTAL), famotidine (PEPCID AC) , colecalciferol (VITAMINS D3; reported as vitamin D), ascorbic acid (VIT-C) and zinc. The reporter stated that after the vaccine (31Dec2020 12:00), the patient had a sore arm and it progressed to Flu like symptoms and pain in her joints. Her whole body ached. The patient mentioned that she has arthritis in her knee and a labrum hip tear, and the vaccine amplified the pain. She also has HSV2 and she haven't had an OB in over 2 years, and she had a bad OB and shingles like pain in her butt/legs/groin to where her skin hurt to touch it. The pain was excruciating. The patient did not received treatment for the adverse event. The patient considered the event as non-serious. She received the COVID-19 vaccine in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of the events was recovering.

Other Meds: PRILOSEC [OMEPRAZOLE]; ZOFRAN MELT; XANAX; LAMICTAL; PEPCID AC; VITAMINS D3; VIT-C;

Current Illness:

ID: 0927629
Sex: F
Age:
State: MD

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Name: exam; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptoms: also had a very hoarse voice; throat starting feeling a little tight; This is a spontaneous report from a contactable Other HCP (patient). A 24-year-old female patient received first dose of BNT162B2 (Lot number: EK9231), intramuscular on 31Dec2020 15:45 at single dose in the left arm for COVID-19 immunization. Medical history included chronic sinusitis from an unknown date and seasonal allergies from an unknown date. Concomitant medication included azithromycin. The patient previously took penicillin and experienced allergies. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that within 10 minutes of receiving the vaccine on 31Dec2020, the patient's throat started feeling a little tight. However, she did not have trouble breathing. The feeling continued for the next 3 hours. She also had a very hoarse voice. The ER suggested that she will be seen. They did an exam and gave her Benadryl which completely resolved her symptoms. The events resulted in emergency room/department or urgent care.

Other Meds:

Current Illness:

ID: 0927630
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20210101; Test Name: coronavirus; Test Result: Positive

Allergies:

Symptoms: she received the Pfizer vaccine on 29Dec2020. She tested positive for coronavirus on 01Jan2021. Is the efficacy of the vaccine after the second dose?; tested positive for coronavirus; This is a spontaneous report from a contactable nurse reported for herself. A female patient of an unspecified age received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration on 29Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. VA nurse calling stating that she received the Pfizer vaccine on 29Dec2020. She tested positive for coronavirus on 01Jan2021. She wanted to know how to proceed with getting her second vaccine, and if the efficacy of the vaccine is after the second dose. The outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and Coronavirus test positive cannot be totally excluded. The case will be reassessed if additional information becomes available.

Other Meds:

Current Illness:

ID: 0927631
Sex: F
Age:
State: MI

Vax Date: 12/30/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: had intermittent abdominal pain that hit at 72 hours (late last night, early this morning); began with nausea and it comes in waves/continues in waves along with the nausea, it comes and goes from moderate severe to low grade; headache; This is a spontaneous report from a contactable nurse (patient). A 57-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 30Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the COVID 19 vaccine on Wednesday close to noon and reported that, "I didn't notice any symptoms until yesterday morning (02Jan2021), I began with nausea and it comes in waves. I did have headache that began Friday evening (01Jan2021) and continues in waves along with the nausea, it comes and goes from moderate severe to low grade. I then had intermittent abdominal pain that hit at 72 hours (late last night, early this morning, 03Jan2021). No diarrhea associated with it. I can't find abdominal pain on the paperwork that was provided to me. is this also one of the expected or reported side effects?" The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0927632
Sex: M
Age:
State: CA

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Constant tinnitus; This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received the first dose of bnt162b2 (Covid 19 vaccine, brand: Pfizer) lot no: EJ1685, via an unspecified route of administration in right arm on 29Dec2020 11:00 at a single dose for COVID-19 immunization. The patient had no other medical history. No known allergies. Concomitant medication included fish oil, allium sativum (GARLIC), ascorbic acid (VITAMINS C), vitamin D, vitamin K, and multivitamin. The patient did not receive other vaccines within 4 weeks prior to the covid vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient experienced constant tinnitus on 30Dec2020 12:00. The event was reported as non-serious. The patient did not receive treatment for the event. The patient had not recovered from the event.

Other Meds: ; GARLIC [ALLIUM SATIVUM]; VITAMINS C; VITAMIN D [VITAMIN D NOS]; VITAMIN K [VITAMIN K NOS]

Current Illness:

ID: 0927633
Sex: F
Age:
State:

Vax Date: 12/17/2020
Onset Date: 12/25/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201225; Test Name: coronavirus; Test Result: Positive

Allergies:

Symptoms: received vaccine on 17Dec2020, then tested positive for coronavirus on 25Dec2020; received vaccine on 17Dec2020, then tested positive for coronavirus on 25Dec2020; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 17Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received vaccine on 17Dec2020, then tested positive for coronavirus on 25Dec2020. The patient was calling to inquire if she can get second vaccine. Outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded. The case will be reassessed if additional information becomes available.

Other Meds:

Current Illness:

ID: 0927634
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/01/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 202012; Test Name: pulse; Result Unstructured Data: Test Result:normal; Test Date: 20201223; Test Name: pulse; Result Unstructured Data: Test Result:120 - 140; Comments: bpm /stayed up

Allergies:

Symptoms: headache; sore throat; pulse stayed up from 120 - 140 bpm; didn't sleep other than that first night except for about 2 hours at a time.; felt like I was about to get a cold, but then it went away; immediately felt sleepy; couldn't function and wasn't feeling well; tired /fatigue; This is a spontaneous report from a non-contactable Nurse. A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on 22Dec2020 at single dose for COVID-19 immunization. Relevant medical history included high blood pressure. Concomitant medications included vitamin B. Patient informed that since an unspecified date in Dec2020 after receiving vaccine she immediately felt sleepy, she asked other's that I work with if they felt sleepy. (None reported feeling sleepy). Patient went back to work and took Vitamin B and Coca Cola. She went to sleep 8 pm that evening and stayed asleep all night, and woke up at 6:-6:30 am. On 23Dec2020 she called out of work because so tired. I went to work the next day (Thursday, 24Dec2020) and couldn't function, she wasn't feeling well but stayed for her entire shift. She woke up the next day with a sore throat. From Wednesday (23Dec2020) her pulse stayed up from 120-140 bpm. The pulse went back to normal on the following Wednesday, it took a week for it to get back to normal. She didn't sleep other than that first night except for about 2 hours at a time. Patient felt like she was about to get a cold, but then it went away. She took her soup and didn't go to work for a week. Patient returned to work on Monday the 28Dec2020. All of her symptoms (fatigue, headache, sore throat) subsided on Wednesday 30Dec2020. Patient also reported that a Co-worker told her that the day after the vaccine said she had chills, not feeling well. Her friend said she will call to report and did not want to provide any demographic information on her behalf. Another Nurse - felt congested and worried. (Yesterday), also no demographic information provided. The Provider (he participated in the clinical trial and had the placebo) received the vaccine the same day as she and he will be calling also. He had body aches and headache. No follow up attempts are possible; Information on lot/batch cannot be obtained. No further information is expected.

Other Meds: VITAMIN B

Current Illness:

ID: 0927635
Sex: F
Age:
State:

Vax Date: 12/24/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; headache; body ache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (age: 41; unit: unknown) received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; Solution for injection; lot number and expiration date: not known), on 24Dec2020 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got vaccinated on 24Dec2020 and after 1 week, which was exactly last Friday afternoon (01Jan2021), she started to experienced chills, headache and body ache. The patient wanted to know if this is normal and how long before it goes away. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0927636
Sex: M
Age:
State:

Vax Date: 12/27/2020
Onset Date: 12/28/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild to moderate pain at injection site.; Severe tension headache that started approximately 24 hours after injection and lasted approximately 18 hours; This is a spontaneous report from a contactable physician (patient). A 32-year-old male patient received the first dose of bnt162b2 (COVID 19 vaccine, brand: Pfizer) lot no: EH9899, via an unspecified route of administration in left arm on 27Dec2020 12:30 at a single for COVID-19 immunization in workplace clinic. There were no relevant medical history and concomitant medications. The patient had no COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. No known allergies. The patient did not receive other vaccines in four weeks or other medications in two weeks. On 28Dec2020 at 12:00 pm, the patient experienced mild to moderate pain at injection site. Severe tension headache that started approximately 24 hours after injection and lasted approximately 18 hours. The events were alleviated by single acetaminophen (TYLENOL) and sleep. The events were reported as non-serious. The patient recovered from the events.

Other Meds:

Current Illness:

ID: 0927637
Sex: F
Age:
State: TX

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19 test; Result Unstructured Data: Test Result:Unknown; Comments: covid test type post vaccination-Blood test

Allergies:

Symptoms: Dizziness; Diarrhea; Sore Arm; Headache; Fatigued; Chills; This is a spontaneous report from a contactable healthcare professional. A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), intramuscular at the left arm on 31Dec2020 13:00 at a single dose for COVID-19 immunization at a hospital. The patient's medical history and concomitant medications were not reported. The patient experienced dizziness, diarrhea, sore arm, headache, fatigued, and chills on 01Jan2021. The patient did not received any treatment for the evets. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has been tested for COVID-19 via a blood test in Jan2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications the patient received within 2 weeks. The patient recovered from the events on an unknown date in Jan2021.

Other Meds:

Current Illness:

ID: 0927638
Sex: F
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/03/2021
Rec V Date: 01/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: feeling very shaky and dizzy when I stand up.; feeling very shaky and dizzy when I stand up.; This is a spontaneous report from a contactable other health professional (patient). A 51-year-old female patient received the first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19, lot number and expiry date not reported), intramuscular on 03Jan2021 13:15 at a single dose on right arm for COVID-19 immunisation. Medical history included none. The patient had no known allergies to medications, food, or other products. There were no concomitant medications. The patient reported, "I'm feeling very shaky and dizzy when I stand up on 03Jan2021 14:30. No treatment was given for the events. The outcome of the events was unknown. The events were considered as non-serious. Facility where the most recent COVID-19 vaccine was administered was in Nursing Home/Senior Living Facility. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications received within 2 weeks of vaccination. Prior to vaccination and since the vaccination, the patient was not diagnosed with COVID-19. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0927639
Sex: M
Age:
State: CO

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201223; Test Name: Body temperature; Result Unstructured Data: Test Result:99.8 Fahrenheit

Allergies:

Symptoms: Injection site soreness only first 24hrs.; fatigue; chills; fever of 99.8 F; body aches; headache; vomiting; Diarrhea; This is a spontaneous report from a contactable other health professional (patient). A 44-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), via an unspecified route of administration on 22Dec2020 14:00 at single dose at right arm for COVID-19 immunization. Medical history included Asthma, no Allergies to medications, food, or other products. Concomitant medications received within 2 weeks of vaccination included budesonide, formoterol fumarate (SYMBICORT), omeprazole. Facility where the most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that injection site soreness only first 24hrs. At 30 hrs, fatigue, chills, fever of 99.8 Fahrenheit (F), body aches, headache, vomiting and diarrhea. These lasted for 24hrs. Diarrhea persisted for 48 hrs. To the best of his knowledge he had not ever been exposed to Covid. The events onset date reported as 23Dec2020 23:00 (pending clarification). Treatment received for the adverse event reported as "Called nurse line". The events were non-serious per the reporter. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was unknown.

Other Meds: SYMBICORT;

Current Illness:

ID: 0927640
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/30/2020
Rec V Date: 01/08/2021
Hospital:

Lab Data: Test Date: 20201230; Test Name: covid test; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: became positive for covid 19; became positive for covid 19; This is a spontaneous report from a contactable other healthcare professional (patient). A female patient of an unspecified age received the first dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine) via an unspecified route of administration on 22Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient she received covid vaccine on 22Dec2020 and on 30Dec2020 became positive for covid 19. The patient wanted to know when she can schedule her 2nd dose. Outcome of the event was unknown. Information about Batch/Lot number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded. The case will be reassessed if additional information becomes available.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm